USD 820.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |
USD 820.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |
USD 820.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |
Recombinant Anti-desmosome/hemidesmosome (Clone F12)
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Fc epsilon R (Clone IE7)
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD23 (Clone CAT-13.9C1)
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-CD154 (Clone IDEC-131 (Toralizumab))
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-CD154 (Clone IDEC-131 (Toralizumab))
Applications | IF |
Reactivities | Human |
Conjugation | Unconjugated |